Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 5,293,000 | 5,660,000 | 5,806,000 | 5,568,000 | 5,198,000 |
| Cost of Goods | 1,973,000 | 2,284,000 | 2,147,000 | 2,109,000 | 1,987,000 |
| Gross Profit | 3,320,000 | 3,376,000 | 3,659,000 | 3,459,000 | 3,211,000 |
| Operating Expenses | 2,283,000 | 2,216,000 | 2,430,000 | 2,276,000 | 2,033,000 |
| Operating Income | 1,037,000 | 1,160,000 | 1,229,000 | 1,183,000 | 1,178,000 |
| Interest Expense | 65,000 | 16,000 | 78,000 | 81,000 | 65,000 |
| Other Income | 40,000 | -305,000 | 36,000 | 20,000 | 26,000 |
| Pre-tax Income | 1,012,000 | 839,000 | 1,187,000 | 1,122,000 | 1,139,000 |
| Income Tax | 213,000 | 180,000 | 261,000 | 252,000 | 255,000 |
| Net Income Continuous | 799,000 | 659,000 | 926,000 | 870,000 | 884,000 |
| Minority Interests | -4,000 | -5,000 | -3,000 | -3,000 | -3,000 |
| Net Income | $796,000 | $655,000 | $923,000 | $867,000 | $880,000 |
| EPS Basic Total Ops | 1.83 | 1.51 | 2.12 | 1.99 | 2.02 |
| EPS Basic Continuous Ops | 1.83 | 1.51 | 2.12 | 1.99 | 2.02 |
| EPS Diluted Total Ops | 1.83 | 1.51 | 2.12 | 1.99 | 2.02 |
| EPS Diluted Continuous Ops | 1.83 | 1.51 | 2.12 | 1.99 | 2.02 |
| EBITDA(a) | $1,533,000 | $1,453,000 | $1,735,000 | $1,735,000 | $1,634,000 |